Consistently, cell-specific genetic ablation of cGAS in microglia protected against brain damage, improved neurobehavioral performance, and reduced cell death after stroke to a similar extent as compared to the pharmacological inhibition of cGAS through A-151 [215]. This evidence concerns the gene CGAS and Stroke.